Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)

1. Font, A.
2. Mellado, B.
3. Climent, M.A.
4. Virizuela, J.A.
5. Oudard, S.
6. Puente, J.
7. Castellano, D.
8. González-del-Alba, A.
9. Pinto, A.
10. Morales-Barrera, R.
11. Rodriguez-Vida, A.
12. Fernandez, P.L.
13. Teixido, C.
14. Jares, P.
15. Aldecoa, I.
16. Gibson, N.
17. Solca, F.
18. Mondal, S.
19. Lorence, R.M.
20. Serra, J.
21. Real, F.X.